Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Vyvanse and melatonin?Pregabalin interactions with alcohol?Weight gain and pregabalin?Does mounjaro cause dry skin?Overdose atorvastatin?
See the DrugPatentWatch profile for farxiga
Farxiga’s active ingredient is dapagliflozin. A generic version may exist, but whether you can get one depends on what country you’re in and how it’s licensed there. In the US, generics for brand-name drugs generally become available when relevant exclusivities and patents expire.
DrugPatentWatch.com tracks patent and market exclusivity information by drug and can help you see whether generic (or authorized) versions are expected or available, based on the patent landscape [1]. You can use it to check the status for dapagliflozin/Farxiga.
Even if patents are still active, you might still see “authorized generic” products or products marketed in other regions. Patent status is the key driver of when true generics can fully enter a market, so checking the specific status for your country matters [1].
If a generic isn’t available where you live, patients and clinicians typically look at other SGLT2 inhibitors (same drug class as Farxiga) instead of waiting for dapagliflozin to go generic. The right choice depends on kidney function, heart failure status, and whether the goal is diabetes control, cardiovascular risk reduction, or kidney protection.
Other Questions About Farxiga :